Atika Capital Management »

Ascendis Pharma AS shares owned by Atika Capital Management

Quarter-by-quarter ownership of Ascendis Pharma AS (ASND) shares owned by Atika Capital Management from 13F filings

Historical chart of Atika Capital Management investment in Ascendis Pharma AS

Tip: Access up to 7 years of quarterly data

All positions including Ascendis Pharma AS held by Atika Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ascendis Pharma AS by Atika Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $16M 61k 266.72

More positions owned by Atika Capital Management

Alkermes SHS Call Option (ALKS)
Vertiv Holdings Com Cl A (VRT)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Spdr Series Trust St Str Sp Biot Put Option (XBI)
Seagate Technology Hldngs Pl Ord Shs (STX)
Ge Vernova Put Option (GEV)
Advanced Micro Devices (AMD)
Eli Lilly & Co. (LLY)
Intel Corporation (INTC)
Micron Technology Put Option (MU)
Echostar Corp Cl A
Vaneck Etf Trust Semiconductr Etf Put Option (SMH)
Guardant Health (GH)
Ishares Tr Expanded Tech Put Option (IGV)
Ciena Corp Com New (CIEN)

View all positions for Atika Capital Management

Top funds holding Ascendis Pharma AS

RA Capital Management
venBio Select Advisor
Westfield Capital Management Company
Jupiter Topco
FMR
Artisan Partners Limited Partnership
BlackRock
Capital Research and Management Company - Division 3
Massachusetts Financial Services
Franklin Resources
Wellington Management Company
T. Rowe Price Associates
American Century Companies
Perceptive Advisors
Principal Financial Group

View all funds holding Ascendis Pharma AS